首站-论文投稿智能助手
典型文献
MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2
文献摘要:
Objective: To improve the prognosis of patients with gastric cancer (GC), more effective therapeutic targets are urgently needed. Increasing evidence indicates that miRNAs are involved in the progression of various tumors, and RAS-associated protein in the brain 31 (RAB31) is upregulated and promotes the progression of multiple malignant tumors. Here, we focused on identifying RAB31-targeted miRNAs and elucidating their potential mechanism in the progression of GC.Methods: RAB31 and miR-378a-3p expression levels were detected in paired fresh GC tissues and GC cell lines. Bioinformatics analysis was used to predict the miRNAs targeting RAB31 and the relationships between RAB31 and other genes. Dual-luciferase reporter assays were applied to verify the targeted interaction relationship. CCK-8, colony formation, flow cytometry, wound healing, and Transwell assays were performed to assess the proliferation, apoptosis, migration, and invasion of GC cells. Tumorsphere formation assays were performed to assess the stemness of gastric cancer stem cells. Related proteins were detected by Western blot. Xenograft assays in nude mice were performed to explore the effect of miR-378a-3p in vivo. Results: We report the first evidence that miR-378a-3p is downregulated in GC, whereas its overexpression inhibits proliferation, invasion, and migration as well as promotes apoptosis in GC cells. Mechanistically, miR-378a-3p inhibits the progression of GC by directly targeting RAB31. Restoring RAB31 expression partially offsets the inhibitory effect of miR-378a-3p. Further research revealed that miR-378a-3p inhibits GLI1/2 in the Hedgehog signaling pathway and attenuates the stemness of gastric cancer stem cells. Finally, xenograft assays showed that miR-378a-3p inhibits GC tumorigenesis in vivo. Conclusions: MiR-378a-3p inhibits GC progression by directly targeting RAB31 and inhibiting the Hedgehog signaling pathway proteins GLI1/2.
文献关键词:
作者姓名:
Xinxin Xu;Yang Li;Guoxiao Liu;Kai Li;Peng Chen;Yunhe Gao;Wenquan Liang;Hongqing Xi;Xinxin Wang;Bo Wei;Hongtao Li;Lin Chen
作者机构:
Medical School of Chinese PLA,Beijing 100853,China;Senior Department of General Surgery,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,China;Department of General Surgery,The 940th Hospital of Joint Logistics Support Force of People's Liberation Army,Lanzhou 730050,China
引用格式:
[1]Xinxin Xu;Yang Li;Guoxiao Liu;Kai Li;Peng Chen;Yunhe Gao;Wenquan Liang;Hongqing Xi;Xinxin Wang;Bo Wei;Hongtao Li;Lin Chen-.MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2)[J].癌症生物学与医学(英文版),2022(12):1662-1682
A类:
RAB31,Tumorsphere
B类:
MiR,378a,3p,acts,suppressor,gastric,cancer,via,directly,targeting,inhibiting,Hedgehog,pathway,proteins,GLI1,Objective,To,improve,prognosis,patients,more,effective,therapeutic,targets,are,urgently,needed,Increasing,evidence,indicates,that,miRNAs,involved,progression,various,tumors,RAS,associated,brain,upregulated,promotes,multiple,malignant,Here,focused,identifying,targeted,elucidating,their,potential,mechanism,Methods,levels,were,detected,paired,fresh,tissues,lines,Bioinformatics,analysis,was,predict,relationships,between,other,Dual,luciferase,reporter,assays,applied,verify,interaction,CCK,colony,formation,flow,cytometry,wound,healing,Transwell,performed,assess,proliferation,apoptosis,migration,invasion,cells,stemness,Related,by,blot,Xenograft,nude,mice,explore,vivo,Results,first,downregulated,whereas,overexpression,inhibits,Mechanistically,Restoring,partially,offsets,inhibitory,Further,research,revealed,signaling,attenuates,Finally,xenograft,showed,tumorigenesis,Conclusions
AB值:
0.43409
相似文献
Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity
Zhang Weiwei;Yan Wenji;Qian Niansong;Han Quanli;Zhang Weitao;Dai Guanghai-Chinese People’s Liberation Army Medical School, Beijing 100853, China;Department of the Third Health Care, The Second Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The First Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The Hainan Medical Center, Chinese People’s Liberation Army General Hospital, Sanya 572022, China;Cancer Center, Beijing Tongren Hospital Affiliated to Capital Medical University, Economic and Technological Development Zone, Beijing 100176, China
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
Fuzheng Kang'ai decoction(扶正抗癌方)inhibits cell proliferation,migration and invasion by modulating mir-21-5p/human phosphatase and tensin homology deleted on chromosome ten in lung cancer cells
LI Jinhua;LIU Chunping;ZHAO Yueyang;WU Wanyin;SUN Pengtao;LI Longmei;YANG Xiaobing;ZHOU Yushu-Department of Ultrasound,Guangdong Provincial Hospital of Chinese Medicine,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Ultrasound,Institute of Ultrasound in Musculoskeletal Sports Medicine,Guangdong Second Provincial General Hospital,Guangzhou 510317,China;State Key Laboratory of Dampness Syndrome of Chinese Medicine,Guangdong Provincial Hospital of Chinese Medicine,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Hematology,Guangdong Provincial Hospital of Chinese Medicine,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Oncology,Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC,Guangdong Provincial Hospital of Chinese Medicine,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。